{"id":111736,"date":"2023-10-12T17:04:30","date_gmt":"2023-10-12T11:34:30","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=111736"},"modified":"2023-10-12T17:04:53","modified_gmt":"2023-10-12T11:34:53","slug":"pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/","title":{"rendered":"Pharma stock in green after it announces expansion of its biologics manufacturing facilities"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1301108505\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-601497655\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h4 class=\"wp-block-heading\" id=\"h-aurobindo-pharma-ltd\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/AUROPHARMA\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Aurobindo Pharma Ltd<\/a>\u00a0<\/strong><\/h4><p>The company has a market capitalisation of Rs. 53,868 Cr, making it a large-cap company. On Thursday the stock gains more than 2.5% and closed 1.6% up at Rs. 914.85 on NSE.<\/p><p>According to NSE filing, the company on September 1, 2022, informed about the expansion of the biologics manufacturing facilities and exploring the possibilities of enter into contract manufacturing operations (CMO) for biological.&nbsp;<\/p><p>In addition, the company informed that CuraTeQ Biologics Pvt Ltd, a wholly-owned subsidiary of the company, along with its subsidiaries has been in discussions with Merck Sharp &amp; Dhomme Singapore Trading Pte. Ltd and its affiliates (MSD) for CMO operations and in this regard parties have signed a limited LOI.<\/p><div class=\"trade-content_5\" id=\"trade-3206256091\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The company\u2019s total revenue grew by 9.8% from Rs. 6,235.9 Cr in Q1 FY23 to Rs. 6,850.5 Cr in Q1 FY24 and for the same period, net profits increased by 9.4% from Rs. 520.3 Cr to Rs. 569.7 Cr.<\/p><p>As per the latest shareholding data, Promoters hold 51.83%, FIIs hold 24.13%, DIIs hold 15.73% and the public hold 8.13% stake in the company.&nbsp;<\/p><p>Aurobindo Pharma Limited manufactures generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It provides formulation in the form of orals, injectables, and over-the-counter drugs;&nbsp; as well as active pharmaceutical ingredients (API) for biosimilars, dermatological, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Sheshadri N<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-3085618740\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.&nbsp; Aurobindo Pharma Ltd\u00a0 The company has a market capitalisation of Rs. 53,868 Cr, making [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[9217,9216,948,936],"class_list":["post-111736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-aurobindo-pharma-latest-news","tag-aurobindo-pharma-share-price","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock in green after it announces expansion of its biologics manufacturing facilities - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock in green after it announces expansion of its biologics manufacturing facilities\" \/>\n<meta property=\"og:description\" content=\"This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-12T11:34:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-12T11:34:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/\",\"name\":\"Pharma stock in green after it announces expansion of its biologics manufacturing facilities - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2023-10-12T11:34:30+00:00\",\"dateModified\":\"2023-10-12T11:34:53+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock in green after it announces expansion of its biologics manufacturing facilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock in green after it announces expansion of its biologics manufacturing facilities - Trade Brains Features","description":"This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock in green after it announces expansion of its biologics manufacturing facilities","og_description":"This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-10-12T11:34:30+00:00","article_modified_time":"2023-10-12T11:34:53+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/","name":"Pharma stock in green after it announces expansion of its biologics manufacturing facilities - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2023-10-12T11:34:30+00:00","dateModified":"2023-10-12T11:34:53+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"This large-cap pharma stock jumps more than 2.5% after its subsidiary signed a Letter of Intent (LOI). This stock has delivered 61% returns in six months and 110% returns in YTD and the stock closed 1.6% away from the 52-week high.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-with-in-green-after-it-announces-expansion-of-its-biologics-manufacturing-facilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock in green after it announces expansion of its biologics manufacturing facilities"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/111736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=111736"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/111736\/revisions"}],"predecessor-version":[{"id":111738,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/111736\/revisions\/111738"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=111736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=111736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=111736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}